{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:40:39Z","timestamp":1792424439426,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    This study investigated the association between ABO and Rh blood group antigens and the clinicopathological features of 418 patients who underwent thyroidectomy for primary thyroid malignancy between December 2016 and June 2023. Since continuous variables did not follow a normal distribution (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05), data were presented as median and interquartile range (IQR). The distribution of ABO blood groups was A (44.5%), O (31.8%), B (16.0%), and AB (7.7%), with 90.9% of patients being Rh-positive. The median age of the cohort was 48 years (IQR: 19). While ABO groups showed no significant difference in age, Rh-negative patients were significantly older than Rh-positive patients (52.5 vs. 48.0 years; p\u2009=\u20090.027). No direct association was identified between ABO groups and the overall clinicopathological features such as tumor size or multifocality (p\u2009&gt;\u20090.05). However, significant differences were observed regarding pathologically confirmed lymph node (LN) involvement. Pathologically confirmed LN involvement was significantly more prevalent in the Rh-negative group compared to the Rh-positive group (15.8% vs. 5.5%; p\u2009=\u20090.027). Most notably, a subgroup analysis revealed that patients with the AB blood group had a significantly higher rate of pathologically confirmed LN involvement compared to non-AB groups (15.6% vs. 5.7%; p\u2009=\u20090.028). To confirm the independence of this association, a multivariable logistic regression analysis was performed. After adjusting for potential confounders including age and tumor size, the AB blood group was independently associated with pathologically confirmed LN metastasis in an exploratory multivariable model (OR: 3.114, 95% CI: 1.085\u20138.938, p\u2009=\u20090.035). These findings suggest that while ABO and Rh blood groups are not significantly associated with most clinicopathological variables in this cohort, they demonstrate specific correlations with nodal disease. These findings may represent exploratory signals that warrant further validation, rather than clinically applicable biomarkers at this stage. Further multicenter prospective studies are warranted to validate these associations across all histological subtypes.\n                  <\/jats:p>","DOI":"10.1186\/s12902-026-02433-5","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T11:23:52Z","timestamp":1784719432000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of ABO and Rh blood groups with clinicopathological features and lymph node involvement in surgically treated thyroid malignancies: a retrospective single-center study"],"prefix":"10.1186","volume":"26","author":[{"given":"Ahmet Zahit","family":"Kaan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Acar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harun","family":"\u00c7ok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serhan","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkan","family":"Somuncu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"2433_CR1","unstructured":"Cancer of the Thyroid - Cancer Stat Facts. SEER https:\/\/seer.cancer.gov\/statfacts\/html\/thyro.html [Accessed April 7, 2025]."},{"key":"2433_CR2","unstructured":"Cancer Today. https:\/\/gco.iarc.who.int\/today\/ [Accessed May 5, 2025]."},{"key":"2433_CR3","doi-asserted-by":"publisher","first-page":"4434","DOI":"10.1210\/jc.2015-3100","volume":"100","author":"N Kwong","year":"2015","unstructured":"Kwong N, Medici M, Angell TE, Liu X, Marqusee E, Cibas ES, Krane JF, Barletta JA, Kim MI, Larsen PR, et al. The Influence of Patient Age on Thyroid Nodule Formation, Multinodularity, and Thyroid Cancer Risk. J Clin Endocrinol Metabolism. 2015;100:4434\u201340. https:\/\/doi.org\/10.1210\/jc.2015-3100.","journal-title":"J Clin Endocrinol Metabolism"},{"key":"2433_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1530\/acta.0.1210197","volume":"121","author":"A Belfiore","year":"1989","unstructured":"Belfiore A, Giuffrida D, La Rosa GL, Ippolito O, Russo G, Fiumara A, Vigneri R, Filetti S. High frequency of cancer in cold thyroid nodules occurring at young age. Acta Endocrinol. 1989;121:197\u2013202. https:\/\/doi.org\/10.1530\/acta.0.1210197.","journal-title":"Acta Endocrinol"},{"key":"2433_CR5","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1089\/thy.2017.0102","volume":"27","author":"Tuttle","year":"2017","unstructured":"Tuttle RM, Haugen B, Perrier ND. Updated American Joint Committee on Cancer\/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why? Thyroid. 2017;27:751\u20136. https:\/\/doi.org\/10.1089\/thy.2017.0102.","journal-title":"Thyroid"},{"key":"2433_CR6","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.ecl.2008.02.003","volume":"37","author":"RL Neff","year":"2008","unstructured":"Neff RL, Farrar WB, Kloos RT, Burman KD. Anaplastic Thyroid Cancer. Endocrinol Metab Clin North Am. 2008;37:525\u201338. https:\/\/doi.org\/10.1016\/j.ecl.2008.02.003.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2433_CR7","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1001\/archsurg.142.3.289","volume":"142","author":"A Machens","year":"2007","unstructured":"Machens A. Abnormal Carcinoembryonic Antigen Levels and Medullary Thyroid Cancer Progression: A Multivariate Analysis. Arch Surg. 2007;142:289. https:\/\/doi.org\/10.1001\/archsurg.142.3.289.","journal-title":"Arch Surg"},{"key":"2433_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0887-7963(90)70247-7","volume":"4","author":"ME Reid","year":"1990","unstructured":"Reid ME, Bird GWG. Associations Between Human Red Cell Blood Group Antigens and Disease. Transfus Med Rev. 1990;4:47\u201355. https:\/\/doi.org\/10.1016\/S0887-7963(90)70247-7.","journal-title":"Transfus Med Rev"},{"key":"2433_CR9","doi-asserted-by":"publisher","first-page":"13308","DOI":"10.3390\/ijms131013308","volume":"13","author":"Z Wang","year":"2012","unstructured":"Wang Z, Liu L, Ji J, Zhang J, Yan M, Zhang J, Liu B, Zhu Z, Yu Y. ABO Blood Group System and Gastric Cancer: A Case-Control Study and Meta-Analysis. IJMS. 2012;13:13308\u201321. https:\/\/doi.org\/10.3390\/ijms131013308.","journal-title":"IJMS"},{"key":"2433_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/BF02933042","volume":"6","author":"V Annese","year":"1990","unstructured":"Annese V, Minervini M, Gabbrielli A, Gambassi G, Manna R. ABO blood groups and cancer of the pancreas. Int J Pancreatol. 1990;6:81. https:\/\/doi.org\/10.1007\/BF02933042.","journal-title":"Int J Pancreatol"},{"key":"2433_CR11","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/jnci\/djp020","volume":"101","author":"BM Wolpin","year":"2009","unstructured":"Wolpin BM, Chan AT, Hartge P, Chanock SJ, Kraft P, Hunter DJ, Giovannucci EL, Fuchs CS. ABO Blood Group and the Risk of Pancreatic Cancer. JNCI J Natl Cancer Inst. 2009;101:424\u201331. https:\/\/doi.org\/10.1093\/jnci\/djp020.","journal-title":"JNCI J Natl Cancer Inst"},{"key":"2433_CR12","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.7314\/APJCP.2013.14.5.2801","volume":"14","author":"Y Urun","year":"2013","unstructured":"Urun Y, Utkan G, Cangir AK, Oksuzoglu OB, Ozdemir N, Oztuna DG, Kocaman G, Coskun HS, Kaplan MA, Yuksel C, et al. Association of ABO Blood Group and Risk of Lung Cancer in a Multicenter Study in Turkey. Asian Pac J Cancer Prev. 2013;14:2801\u20133. https:\/\/doi.org\/10.7314\/APJCP.2013.14.5.2801.","journal-title":"Asian Pac J Cancer Prev"},{"key":"2433_CR13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/09720073.2005.11890905","volume":"7","author":"K Guleria","year":"2005","unstructured":"Guleria K, Singh HP, Kaur H, Sambyal V. ABO Blood Groups in Gastrointestinal Tract (GIT) and Breast Carcinoma Patients. Anthropol. 2005;7:189\u201392. https:\/\/doi.org\/10.1080\/09720073.2005.11890905.","journal-title":"Anthropol"},{"key":"2433_CR14","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1158\/1055-9965.EPI-10-1250","volume":"20","author":"H Khalili","year":"2011","unstructured":"Khalili H, Wolpin BM, Huang ES, Giovannucci EL, Kraft P, Fuchs CS, Chan AT. ABO Blood Group and Risk of Colorectal Cancer. Cancer Epidemiol Biomarkers Prev. 2011;20:1017\u201320. https:\/\/doi.org\/10.1158\/1055-9965.EPI-10-1250.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2433_CR15","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.canep.2012.07.001","volume":"36","author":"H-K Joh","year":"2012","unstructured":"Joh H-K, Cho E, Choueiri TK. ABO blood group and risk of renal cell cancer. Cancer Epidemiol. 2012;36:528\u201332. https:\/\/doi.org\/10.1016\/j.canep.2012.07.001.","journal-title":"Cancer Epidemiol"},{"key":"2433_CR16","doi-asserted-by":"publisher","first-page":"e088016","DOI":"10.1136\/bmjopen-2024-088016","volume":"14","author":"H Shi","year":"2024","unstructured":"Shi H, Yao J, Jiang C, Xu W, Jiang Z, Chen Y, Qian Y. ABO blood types and head and neck cancer: a systematic review with meta-analysis of observational studies. BMJ Open. 2024;14:e088016. https:\/\/doi.org\/10.1136\/bmjopen-2024-088016.","journal-title":"BMJ Open"},{"key":"2433_CR17","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.7314\/APJCP.2014.15.11.4643","volume":"15","author":"B-L Zhang","year":"2014","unstructured":"Zhang B-L, He N, Huang Y-B, Song F-J, Chen K-X. ABO Blood Groups and Risk of Cancer: a Systematic Review and Meta-analysis. Asian Pac J Cancer Prev. 2014;15:4643\u201350. https:\/\/doi.org\/10.7314\/APJCP.2014.15.11.4643.","journal-title":"Asian Pac J Cancer Prev"},{"key":"2433_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3109\/10408363.2012.708647","volume":"49","author":"M Franchini","year":"2012","unstructured":"Franchini M, Favaloro EJ, Targher G, Lippi G. ABO blood group, hypercoagulability, and cardiovascular and cancer risk. Crit Rev Clin Lab Sci. 2012;49:137\u201349. https:\/\/doi.org\/10.3109\/10408363.2012.708647.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"2433_CR19","doi-asserted-by":"publisher","first-page":"98","DOI":"10.5152\/imj.2015.14890","volume":"16","author":"Z\u0130 Yuksel Salduz","year":"2015","unstructured":"Yuksel Salduz Z\u0130, Cetin G, Karatoprak C, Ozder A, Bilginc M, Gultepe I, Gul O. ABO and Rh Blood Group Distribution in \u0130stanbul Province (Turkey). Istanbul Med J. 2015;16:98\u2013100. https:\/\/doi.org\/10.5152\/imj.2015.14890.","journal-title":"Istanbul Med J"},{"key":"2433_CR20","doi-asserted-by":"publisher","first-page":"e34564","DOI":"10.1097\/MD.0000000000034564","volume":"102","author":"O Dogan","year":"2023","unstructured":"Dogan O. Evaluation of ABO\/Rh blood group distributions in papillary thyroid cancer patients. Med (Baltim). 2023;102:e34564. https:\/\/doi.org\/10.1097\/MD.0000000000034564.","journal-title":"Med (Baltim)"},{"key":"2433_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1080\/07435800.2019.1695261","volume":"45","author":"AA Tam","year":"2020","unstructured":"Tam AA, \u00d6zdemir D, Fak\u0131 S, Bilginer MC, Ersoy R, \u00c7ak\u0131r B. ABO Blood Groups, Rh Factor, and Thyroid Cancer Risk: To \u2018B\u2019 or Not to \u2018B\u2019. Endocr Res. 2020;45:137\u201346. https:\/\/doi.org\/10.1080\/07435800.2019.1695261.","journal-title":"Endocr Res"},{"key":"2433_CR22","doi-asserted-by":"publisher","DOI":"10.5505\/tjo.2020.2066","author":"M Oroei","year":"2020","unstructured":"Oroei M. The Estimation of Thyroid Cancer Risk based on Type 2 Diabetes Mellitus and ABO Blood Group. TJ Oncol. 2020. https:\/\/doi.org\/10.5505\/tjo.2020.2066.","journal-title":"TJ Oncol"},{"key":"2433_CR23","doi-asserted-by":"publisher","unstructured":"Ghunaim M, Alkhalifah Z, Almontashri A, Aljehani M, Alhammadi M, Bahakim A, Faleh D, AlHarthi M, Malibary N. Research Title: ABO blood types can play a role in determining prognosis of thyroid cancer in adult patients: a single-centre retrospective study 2023. https:\/\/doi.org\/10.21203\/rs.3.rs-3597876\/v1","DOI":"10.21203\/rs.3.rs-3597876\/v1"},{"key":"2433_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s10353-025-00869-y","author":"\u0130 Kamac\u0131","year":"2025","unstructured":"Kamac\u0131 \u0130, Soylu S, Teks\u00f6z S. Do rhesus factor and ABO blood group influence the risk of papillary thyroid cancer? Eur Surg. 2025. https:\/\/doi.org\/10.1007\/s10353-025-00869-y.","journal-title":"Eur Surg"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02433-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02433-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02433-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:02:07Z","timestamp":1792422127000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02433-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2433"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02433-5","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"2 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of University of Health Sciences, Kanuni Sultan Suleyman Training and Research Hospital (Date: 21.09.2023 \/ No: 2023.09.115). Due to the retrospective and anonymous nature of the study, the requirement for obtaining written informed consent to participate was formally waived by the Ethics Committee of University of Health Sciences, Kanuni Sultan Suleyman Training and Research Hospital.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"323"}}